Randolph M. Johnson

Randolph M. Johnson

Corporate Officer/Principal bei American Society for Pharmacology & Experimental Therapeutic

Health Technology
Consumer Services
Electronic Technology

Profil

Dr. Randolph M.
Johnson
is Executive Vice President-Clinical Development at Endonovo Therapeutics, Inc., Chief Operating Officer at AtheroNova, Inc., CDO & EVP-Preclinical Development at Cortexyme, Inc., a Member at American Society for Pharmacology & Experimental Therapeutic, a Member at Society For Neuroscience and a Member at The Endocrine Society.
Dr. Johnson was previously employed as Chief Technology Officer & VP-Research by KAI Pharmaceuticals, Inc., Senior Vice President-Research by Cellgate, Inc., Senior Vice President-Research by CellGate Technologies LLC, Vice President-Pharmacology & Toxicology by DURECT Corp., a Principal by Genentech, Inc., Director-Research & Development by Syntex Research Centre, and a Professor by University of Virginia.
He received his undergraduate degree from The California State University, a graduate degree from The California State University and a doctorate degree from the University of South Carolina.

Aktive Positionen von Randolph M. Johnson

UnternehmenPositionBeginn
American Society for Pharmacology & Experimental Therapeutic Corporate Officer/Principal -
Corporate Officer/Principal -
The Endocrine Society Corporate Officer/Principal -
Alle aktiven Positionen von Randolph M. Johnson

Ehemalige bekannte Positionen von Randolph M. Johnson

UnternehmenPositionEnde
ATHERONOVA INC. Geschäftsführer -
ENDONOVO THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter -
Corporate Officer/Principal -
University of Virginia Corporate Officer/Principal -
Technik-/Wissenschafts-/F&E-Leiter -
Sehen Sie sich die Erfahrung von Randolph M. Johnson im Detail an

Ausbildung von Randolph M. Johnson

The California State University Graduate Degree
University of South Carolina Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Randolph M. Johnson im Detail an

Beziehungen

66

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
DURECT CORPORATION

Health Technology

ENDONOVO THERAPEUTICS, INC.

Health Technology

Private Unternehmen9

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

American Society for Pharmacology & Experimental Therapeutic

Commercial Services

The Endocrine Society

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Randolph M. Johnson